Citadel Advisors »

Cg Oncology shares owned by Citadel Advisors

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 342k 37.73
2024-06-30 $16M 508k 31.57
2024-03-31 $12M 279k 43.90

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Cg Oncology

Decheng Capital
TCG Crossover Management
BlackRock
Braidwell
Vanguard Group
BlackRock
Avidity Partners Management
Henderson Group
RA Capital Management
Franklin Resources
Geode Capital Management
Alliancebernstein
BVF
State Street Corporation
Cormorant Asset Management

View all funds holding Cg Oncology